Dr Alan Bernstein has been appointed president and CEO of the prestigious Canadian Institute for Advanced Research (CIFAR), effective May 1st. Bernstein replaces longstanding CIFAR head Chaviva Hosek, who announced more than one year ago that she was stepping down after 11 years (R$, December 13/10). Bernstein recently completed a five-year term as executive director of the New York City-based Global HIV Vaccine Enterprise. Prior to that, he served for seven years as the inaugural president or the Canadian Institutes of Health Research. Bernstein received a PhD from the Univ of Toronto. After working at the Ontario Cancer Institute, he joined the Samuel Lunenfeld Research Institute in 1985, working his way up to director of research (1994-2000).
The Communications Research Centre has lost two key people to retirement. executive VP <